SKIN
Income statement / Annual
Last year (2025), Beauty Health Company (The)'s total revenue was $300.80 M,
a decrease of 10.02% from the previous year.
In 2025, Beauty Health Company (The)'s net income was -$9.50 M.
See Beauty Health Company (The),s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$300.80 M |
$334.29 M |
$397.99 M |
$365.88 M |
$260.09 M |
$119.09 M |
$166.62 M |
$112.31 M |
| Cost of Revenue |
$104.40 M
|
$152.00 M
|
$242.88 M
|
$117.10 M
|
$81.55 M
|
$51.89 M
|
$60.11 M
|
$39.34 M
|
| Gross Profit |
$196.40 M
|
$182.30 M
|
$155.11 M
|
$248.78 M
|
$178.54 M
|
$67.20 M
|
$106.51 M
|
$72.98 M
|
| Gross Profit Ratio |
0.65
|
0.55
|
0.39
|
0.68
|
0.69
|
0.56
|
0.64
|
0.65
|
| Research and Development Expenses |
$5.60 M
|
$6.30 M
|
$10.10 M
|
$8.44 M
|
$8.20 M
|
$3.41 M
|
$4.61 M
|
$2.40 M
|
| General & Administrative Expenses |
$117.90 M
|
$125.46 M
|
$131.43 M
|
$106.10 M
|
$98.69 M
|
$30.65 M
|
$26.66 M
|
$17.77 M
|
| Selling & Marketing Expenses |
$93.60 M
|
$118.31 M
|
$144.50 M
|
$160.08 M
|
$111.58 M
|
$50.32 M
|
$61.77 M
|
$42.74 M
|
| Selling, General & Administrative Expenses |
$211.50 M
|
$243.77 M
|
$275.93 M
|
$266.18 M
|
$210.27 M
|
$80.97 M
|
$88.44 M
|
$60.51 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$9.00 K
|
| Operating Expenses |
$217.10 M
|
$250.07 M
|
$286.03 M
|
$274.62 M
|
$218.47 M
|
$84.38 M
|
$93.05 M
|
$62.92 M
|
| Cost And Expenses |
$321.50 M
|
$402.07 M
|
$528.91 M
|
$391.72 M
|
$300.01 M
|
$136.27 M
|
$153.16 M
|
$102.25 M
|
| Interest Income |
$8.95 M
|
$16.64 M
|
$23.17 M
|
$9.18 M
|
$39.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$19.30 M
|
$10.41 M
|
$13.65 M
|
$13.39 M
|
$11.78 M
|
$21.28 M
|
$17.09 M
|
$10.05 M
|
| Depreciation & Amortization |
$20.84 M
|
$29.48 M
|
$34.68 M
|
$22.87 M
|
$17.93 M
|
$14.40 M
|
$13.74 M
|
$11.50 M
|
| EBITDA |
$33.00 K |
$10.34 M |
-$53.57 M |
$81.60 M |
-$350.93 M |
-$2.81 M |
$27.90 M |
$21.56 M |
| EBITDA Ratio |
0
|
0.03
|
-0.13
|
0.22
|
-1.35
|
-0.02
|
0.17
|
0.19
|
| Operating Income Ratio |
-0.07
|
-0.2
|
-0.33
|
-0.07
|
-0.15
|
-0.14
|
0.08
|
0.09
|
| Total Other Income/Expenses Net |
$14.87 M
|
$38.22 M
|
$29.03 M
|
$71.18 M
|
-$340.71 M
|
-$21.30 M
|
-$16.40 M
|
-$10.05 M
|
| Income Before Tax |
-$5.94 M
|
-$29.55 M
|
-$101.89 M
|
$45.34 M
|
-$380.64 M
|
-$38.48 M
|
-$2.94 M
|
$10.00 K
|
| Income Before Tax Ratio |
-0.02
|
-0.09
|
-0.26
|
0.12
|
-1.46
|
-0.32
|
-0.02
|
0
|
| Income Tax Expense |
$3.58 M
|
-$452.00 K
|
-$1.77 M
|
$1.12 M
|
-$1.88 M
|
-$9.31 M
|
-$1.30 M
|
$327.00 K
|
| Net Income |
-$9.50 M
|
-$29.10 M
|
-$100.12 M
|
$44.22 M
|
-$378.76 M
|
-$29.18 M
|
-$1.64 M
|
-$317.00 K
|
| Net Income Ratio |
-0.03
|
-0.09
|
-0.25
|
0.12
|
-1.46
|
-0.24
|
-0.01
|
-0
|
| EPS |
-0.08 |
-0.23 |
-0.76 |
0.3 |
-3.67 |
-0.85 |
-0.051 |
-0.0025 |
| EPS Diluted |
-0.16 |
-0.36 |
-0.76 |
-0.23 |
-3.67 |
-0.85 |
-0.051 |
-0.0025 |
| Weighted Average Shares Out |
$126.38 M
|
$123.83 M
|
$131.68 M
|
$147.55 M
|
$102.11 M
|
$34.29 M
|
$32.14 M
|
$125.40 M
|
| Weighted Average Shares Out Diluted |
$135.80 M
|
$142.49 M
|
$131.68 M
|
$148.51 M
|
$102.11 M
|
$34.29 M
|
$32.14 M
|
$125.40 M
|
| Link |
|
|
|
|
|
|
|
|
